Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
This comparison highlights the pros and cons of total market and total world retirement strategies to help you decide which better fits your retirement plan.
28,570 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
CrowdStrike is set to report Q1 results after the close, with analysts expecting revenue around $1.39 billion and sol...
Polestar faces a pivotal period as it refines profitability and expansion amid a crowded EV field. This report outlin...
Figure Technology Solutions is acquiring Kiavi in a $717 million deal, expanding its first-lien lending and investor-...
BigBear.AI released its latest quarterly results after the bell, showing a sharp balance-sheet improvement and a path...
With the MiCA deadline looming, a vast majority of EU crypto firms have not completed full licensing. Only a fraction...
As 2026 begins, homebuilders contend with thinner margins, stubborn demand, and growing war-risk headwinds, forcing l...
As AI demand drives Marvell Technology higher, investors debate whether the stock can reach $300 this summer. Here’s ...
The Senate cleared a sweeping housing package in a rare bipartisan vote, setting up aHouse showdown and potential shi...
As AI-driven stocks wobble between skepticism and momentum, HSBC strategists say a turn in valuations could lift pric...
AI is reshaping hiring in three AI-driven domains, even as revenue growth decouples from headcount. The shift signals...
AMD has surged in 2026 and is flirting with a $1 trillion market cap. This deep dive examines the drivers, risks, and...